Have confidence in the data that drives government pricing computations.Missed transaction-level details can skew government pricing computations and impact your bottom line by millions of dollars. That’s why it is imperative to have confidence in the data that drives...
Why Medicaid is a pharma company’s most demanding government program in terms of potential impact and resources.For both brand and generic pharma companies, the most demanding of the government programs, in terms of financial impact and required resources, is often...
Avoiding Costly Government Pricing MistakesBasic steps pharmaceutical manufacturers should employ to avoid erroneous government pricing calculationsManaging Government Pricing (GP) computations can feel a bit like walking through a cave without a flashlight. Even an...
Continued Emergence of Drug Price Disclosure LegislationTips for staying compliant with an accelerating trendThe summer of 2019 saw an 86 percent increase in the number of states enacting pharmaceutical drug price disclosure laws. This paper, our second in a series...
Drug Price Disclosure LegislationFour steps to staying ahead and staying compliantMany states have moved to enact mandatory pharmaceutical price disclosure laws that would increase price transparency to address prescription drug costs (Fig. 1, pg. 3). In 2018, states...